跳至主要内容
临床试验/ACTRN12612001227886
ACTRN12612001227886撤回未知

The Role of Renin-Angiotensin System and Other Markers in Haemangioma in infants and young children with growing problematic haemangiomas

Hutt Valley DHB0 个研究点目标入组 40 人开始时间: 2012年11月20日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 Months 至 18 Months(—)
性别
All

入选标准

  • 1. Infants and young children aged 2 to 18 months with growing problematic haemangiomas undergoing Propranolol treatment or surgery, whose caregivers have already decided on the proposed treatment and have given written consent.
  • 2. Non-haemangioma children aged 3 – 18 months undergoing elective surgery for whose caregiver have given written consent.

排除标准

  • 1. Caregivers who would not consent for the child to participate in this study.

研究者

相似试验